UNS reports positive results from Phase I trial of UB-311 to treat Alzheimer ’s disease

United Neuroscience (UNS) has reported positive results from the Phase I clinical trial of UB-311 for the treatment of patients suffering from Alzheimer ’s disease (AD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news